BioLineRx and Hemispherian Announce New Preclinical Data Demonstrating Strong Synergistic Effect between GLIX1 and PARP Inhibitor in a Patient-Derived Ovarian Cancer Xenograft Model

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/25/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. RNG
7. SPY
8. TMUS
9. UNP
10. GOOGL

Go back to BioLineRx and Hemispherian Announce New Preclinical Data Demonstrating Strong Synergistic Effect between GLIX1 and PARP Inhibitor in a Patient-Derived Ovarian Cancer Xenograft Model
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.82 -0.04 (1.4%)
Previous Close $2.86    52 Week High $1.63 
Open $2.86    52 Week Low $0.71 
Day High $3.04    P/E N/A 
Day Low $2.82    EPS $0.00 
Volume 2,697       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.82 -0.04 (1.4%)
Previous Close $2.86    52 Week High $1.63 
Open $2.86    52 Week Low $0.71 
Day High $3.04    P/E N/A 
Day Low $2.82    EPS $0.00 
Volume 2,697